Enzon Pharmaceuticals, Inc. (BST:EZ1)
Germany
· Delayed Price · Currency is EUR 0.0755
-0.0040 (-5.03%)
At close: Jul 3, 2025
Enzon Pharmaceuticals Company Description
Enzon Pharmaceuticals, Inc. does not have significant operations.
Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002.
Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.
Enzon Pharmaceuticals, Inc.
| Country | United States |
| Founded | 1981 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 1 |
| CEO | Richard Feinstein |
Contact Details
Address: 20 Commerce Drive Cranford, Delaware 07016 United States | |
| Phone | 732 980 4500 |
| Website | enzon.com |
Stock Details
| Ticker Symbol | EZ1 |
| Exchange | Stuttgart Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Richard Feinstein | Chief Executive Officer |
| Richard Feinstein | Chief Financial Officer |